Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients

MLA

Alessandra Curioni-Fontecedro, et al. Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....03016484fc48dde943c911c3f64c90bb&authtype=sso&custid=ns315887.

APA

Alessandra Curioni-Fontecedro, Maries van den Broek, Davide Soldini, Christian Britschgi, Verena Tischler, Rolf A. Stahel, Emanuela Felley-Bosco, Paul Stolzmann, Walter Weder, Bart Vrugt, Isabelle Opitz, Beata Bode, Martina Friess, Hideo Yagita, Stefanie Hiltbrunner, Virginia Cecconi, & Paulino Tallón de Lara. (2023). Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients.

Chicago

Alessandra Curioni-Fontecedro, Maries van den Broek, Davide Soldini, Christian Britschgi, Verena Tischler, Rolf A. Stahel, Emanuela Felley-Bosco, et al. 2023. “Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....03016484fc48dde943c911c3f64c90bb&authtype=sso&custid=ns315887.